Triazolam
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00897 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 7 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 2 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 3 | benign paroxysmal torticollis of infancy | KG + DL |
| 4 | agoraphobia | KG + DL |
| 5 | Wernicke-Korsakoff syndrome | KG + DL |
| 6 | restless legs syndrome | KG + DL |
| 7 | alcohol withdrawal | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.